Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Evaluation of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates.

Trial Profile

An Evaluation of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 11 Nov 2017

At a glance

  • Drugs Moxifloxacin/dexamethasone (Primary) ; Dexamethasone; Moxifloxacin
  • Indications Bacterial infections; Ophthalmic infections
  • Focus Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 04 Dec 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 05 Mar 2012 Planned end date changed from 1 Mar 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.
    • 12 Feb 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top